Use of the VisuMax™ Femtosecond Laser
NCT: NCT01638390 · COMPLETED
NCT IDNCT01638390
StatusCOMPLETED
Start Date2012-07
Completion2016-04
Brief Summary
The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or elimination of myopia from ≥ -1.00 D to ≤ -8.00 D with ≤ -0.50 D cylinder and MRSE (Manifest Refractive Spherical Equivalent) ≤ -8.25 D.
Frequently Asked Questions
What is Use of the VisuMax™ Femtosecond Laser?
Use of the VisuMax™ Femtosecond Laser is a clinical trial registered under NCT01638390. Current status: COMPLETED.
What is the status of NCT01638390?
The current status of NCT01638390 (Use of the VisuMax™ Femtosecond Laser) is: COMPLETED.
When did Use of the VisuMax™ Femtosecond Laser start?
Use of the VisuMax™ Femtosecond Laser started on 2012-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.